Literature DB >> 10907999

Fatal liver failure after high-dose glucocorticoid pulse therapy in a patient with severe thyroid eye disease.

M Weissel, W Hauff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10907999     DOI： 10.1089/thy.2000.10.521

Source DB:  PubMed          Journal:  Thyroid        ISSN： 1050-7256            Impact factor:   6.568


× No keyword cloud information.
  20 in total

Review 1.  Novel aspects of immunosuppressive and radiotherapy management of Graves' ophthalmopathy.

Authors:  C Marcocci; M Marinò; R Rocchi; F Menconi; E Morabito; A Pinchera
Journal:  J Endocrinol Invest       Date:  2004-03       Impact factor: 4.256

Review 2.  An update on medical management of Graves' ophthalmopathy.

Authors:  L Bartalena; C Marcocci; M L Tanda; E Piantanida; A Lai; M Marinò; A Pinchera
Journal:  J Endocrinol Invest       Date:  2005-05       Impact factor: 4.256

Review 3.  Acute liver damage following intravenous glucocorticoid treatment for Graves' ophthalmopathy.

Authors:  Mariacarla Moleti; Giuseppe Giuffrida; Giacomo Sturniolo; Giovanni Squadrito; Alfredo Campennì; Silvia Morelli; Efisio Puxeddu; Eleonora Sisti; Francesco Trimarchi; Francesco Vermiglio; Michele Marinò
Journal:  Endocrine       Date:  2016-03-22       Impact factor: 3.633

4.  Autoimmune hepatitis during intravenous glucocorticoid pulse therapy for Graves' ophthalmopathy treated successfully with glucocorticoids themselves.

Authors:  M Marinò; E Morabito; M A Altea; E Ambrogini; F Oliveri; M R Brunetto; L E Pollina; D Campani; P Vitti; L Bartalena; A Pincheral; C Marcocci
Journal:  J Endocrinol Invest       Date:  2005-03       Impact factor: 4.256

5.  [Driving competency after combined treatment with methylprednisolone and orbital radiotherapy for endocrine orbitopathy].

Authors:  I Sterker; H Tegetmeyer; K Papsdorf; D Führer
Journal:  Ophthalmologe       Date:  2010-10       Impact factor: 1.059

Review 6.  Acute thyroid eye disease (TED): principles of medical and surgical management.

Authors:  D H Verity; G E Rose
Journal:  Eye (Lond)       Date:  2013-02-15       Impact factor: 3.775

7.  Liver injury after methylprednisolone pulses: A disputable cause of hepatotoxicity. A case series and literature review.

Authors:  Miguel Eugenio Zoubek; José Pinazo-Bandera; Aida Ortega-Alonso; Nelia Hernández; Javier Crespo; Fernando Contreras; Inmaculada Medina-Cáliz; Judith Sanabria-Cabrera; Rocío Sanjuan-Jiménez; Andrés González-Jiménez; Miren García-Cortés; M Isabel Lucena; Raúl J Andrade; Mercedes Robles-Díaz
Journal:  United European Gastroenterol J       Date:  2019-03-24       Impact factor: 4.623

8.  Prospectively recorded and MedDRA-coded safety data of intravenous methylprednisolone therapy in Graves' orbitopathy.

Authors:  M Riedl; E Kolbe; E Kampmann; I Krämer; G J Kahaly
Journal:  J Endocrinol Invest       Date:  2015-01-10       Impact factor: 4.256

Review 9.  The eye and thyroid disease.

Authors:  Ajay E Kuriyan; Richard P Phipps; Steven E Feldon
Journal:  Curr Opin Ophthalmol       Date:  2008-11       Impact factor: 3.761

10.  Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves' orbitopathy.

Authors:  E Sabini; E Sisti; B Coco; M Leo; I Ionni; F Menconi; M A Profilo; B Mazzi; R Rocchi; F Latrofa; P Vitti; M Brunetto; C Marcocci; M Marinò
Journal:  J Endocrinol Invest       Date:  2016-07-27       Impact factor: 4.256
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.